We are live on ! Find out more
IMMU

Immunomedics Inc
IMMU

Delisted

IMMU was delisted on the 22nd of October, 2020.

Back to rankings

207 hedge funds and large institutions have $3.08B invested in Immunomedics Inc in 2018 Q3 according to their latest regulatory filings, with 41 funds opening new positions, 81 increasing their positions, 53 reducing their positions, and 26 closing their positions.

New
Increased
Maintained
Reduced
Closed

58% more first-time investments, than exits

New positions opened: 41 | Existing positions closed: 26

53% more repeat investments, than reductions

Existing positions increased: 81 | Existing positions reduced: 53

8% more funds holding

Funds holding: 192 → 207 (+15)

0% more funds holding in top 10

Funds holding in top 10: 9 → 9 (0)

11% less capital invested

Capital invested by funds: $3.48B → $3.08B (-$400M)

44% less call options, than puts

Call options by funds: $99.7M | Put options by funds: $177M

Holders
207
Holders Change
+15
Holders Change %
+7.81%
% of All Funds
4.73%
Holding in Top 10
9
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.21%
New
41
Increased
81
Reduced
53
Closed
26
Calls
$99.7M
Puts
$177M
Net Calls
-$76.9M
Net Calls Change
-$11.5M

Top Buyers

Rank Fund Capital Flow
1
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$90.5M
2
CS
Candriam SCA
Luxembourg
+$24.3M
3
BlackRock
BlackRock
New York
+$23.1M
4
WRF
Waddell & Reed Financial
Kansas
+$17.8M
5
Deutsche Bank
Deutsche Bank
Germany
+$16.8M

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$70.8M
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$69.5M
3
ACP
Acuta Capital Partners
California
-$63.8M
4
O
OrbiMed
New York
-$14.6M
5
Citadel Advisors
Citadel Advisors
Florida
-$12.3M
Name Holding Trade Value Shares
Change 		Change in
Stake
TPWA
201
TRUE Private Wealth Advisors
Oregon
$3.13K +$3.55K +150 New
OWA
202
One Wealth Advisors
California
$2K – – –
CWSR
203
Chessman Wealth Strategies RIA
Texas
$2K +$2.37K +100 New
WSTAM
204
Wilbanks Smith & Thomas Asset Management
Virginia
$2K +$2.37K +100 New
FGAM
205
Financial Gravity Asset Management
Texas
$1K +$568 +24 New
FCM
206
Farallon Capital Management
California
– -$9.47M -400,000 Closed
OA
207
Omega Advisors
New York
– -$9.47M -400,000 Closed
Balyasny Asset Management
208
Balyasny Asset Management
Illinois
– -$9.24M -390,185 Closed
CI
209
Cowen Inc
New York
– -$3.55K -150,000 Closed
UOC
210
UBS O'Connor
Illinois
– -$2.37M -100,000 Closed
Federated Hermes
211
Federated Hermes
Pennsylvania
– -$2.21M -93,223 Closed
EP
212
Eversept Partners
New York
– -$1.3M -55,000 Closed
PVI
213
Pura Vida Investments
New York
– -$1.19M -50,400 Closed
QIM
214
Quantitative Investment Management
Virginia
– -$1.05M -44,500 Closed
EGI
215
EAM Global Investors
California
– -$892K -37,667 Closed
SSA
216
Schonfeld Strategic Advisors
New York
– -$850K -35,900 Closed
MWNA
217
Marshall Wace North America
New York
– -$554K -23,411 Closed
AB
218
Amalgamated Bank
New York
– -$472K -19,954 Closed
ACM
219
Asymmetry Capital Management
California
– -$466K -19,695 Closed
BCM
220
BlueCrest Capital Management
Jersey
– -$459K -19,400 Closed
CA
221
Calton & Associates
Florida
– -$294K -12,500 Closed
PCM
222
Prelude Capital Management
New York
– -$182K -7,680 Closed
SG Americas Securities
223
SG Americas Securities
New York
– -$170K -7,171 Closed
CF
224
Centaurus Financial
California
– -$71K -3,000 Closed
FIA
225
FNY Investment Advisers
New York
– -$71.1K -3,000 Closed
6 7 8
9
10

IMMU Hedge Fund Activity: Q3 2018 in Review

207 of the 4,375 institutional investors tracked by Wall St. Rank reported a position in Immunomedics Inc (IMMU) for Q3 2018, worth a combined $3.08B — down 11% from $3.48B a quarter earlier.

Buyers outnumbered sellers: 41 funds opened new IMMU positions and 26 closed out — a net gain of 15 holders — while 81 added to existing stakes and 53 trimmed.

The largest buyer was T. Rowe Price Associates, adding an estimated $90.5M. The largest seller was Millennium Management, cutting an estimated $70.8M.

  • 207 institutional investors held Immunomedics Inc (IMMU) as of Q3 2018, up from 192 in Q2 2018.
  • Funds reported $3.08B of Immunomedics Inc stock for Q3 2018, down 11% quarter-over-quarter.
  • 41 funds opened new Immunomedics Inc positions in Q3 2018 and 26 closed out, a net change of +15 holders.
  • The largest Immunomedics Inc buyer in Q3 2018 was T. Rowe Price Associates, an estimated $90.5M added.
  • The largest Immunomedics Inc seller in Q3 2018 was Millennium Management, an estimated $70.8M sold.

Based on aggregated 13F filings for Q3 2018.